COURTNEY TOMLINSON: Open Payments
NPI 1952568826 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,731 in 84 payments from 36 companies in 2025. Trend: 2023 $494 · 2024 $1,527 · 2025 $1,731
Food & beverage: $1,731
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $116 |
| AstraZeneca Pharmaceuticals LP | 6 | $116 |
| Genentech USA, Inc. | 6 | $106 |
| Daiichi Sankyo Inc. | 4 | $102 |
| Merck Sharp & Dohme LLC | 4 | $92 |
| ABBVIE INC. | 4 | $87 |
| Exelixis Inc. | 5 | $80 |
| Incyte Corporation | 4 | $79 |
| EMD Serono, Inc. | 3 | $79 |
| Celgene Corporation | 3 | $76 |
Products named: KEYTRUDA, CABOMETYX, Enhertu, MONJUVI, REBLOZYL, Polivy, BRAFTOVI, Zoladex.
Industry payments across MS — which companies pay providers there.
